Box score
Artax Biopharma, Inc.
Reported $6M sold in a new Form D filed August 9, 2024 (Cambridge, Massachusetts).
- Biggest raise
- $6M filed Aug 9, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- Cambridge, Massachusetts
- Season rank
- #464 of 1,389 in the Bio & Health League; #2863 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-05 | Amendment | $19M | $19M | SEC |
| 2025-07-29 | Amendment | $11M | $11M | SEC |
| 2024-08-09 | New notice | $6M | $8M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1587661.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Dash Bio, Inc. rookie | Bio & Health | $6.1M |
| 2 | Elicio Therapeutics, Inc. | Bio & Health | $6M |
| 3 | Transition Bio, Inc. | Bio & Health | $6M |
| 4 | Scipher Medicine Corp | Bio & Health | $5.8M |
| 5 | Circinus Medical Technology LLC | Bio & Health | $5.8M |
| 6 | Kytopen Corp. | Bio & Health | $5.7M |